Yongping Chen (Cro

Yongping Chen is a seasoned professional in the fields of oncology, inflammation, toxicity, and pharmacokinetics/pharmacodynamics (PK/PD) with extensive experience in both academia and industry. Currently serving as Senior Study Director for in vivo Pharmacology at Noble Life Sciences Inc since January 2023, Yongping previously held the position of Director of Operations and Senior Scientist at Washington Biotechnology Inc from January 2013 to January 2023. Earlier career highlights include a Postdoctoral Fellowship at The Johns Hopkins University School of Medicine from January 2009 to December 2012 and a postdoctoral role at the University of Washington from November 2007 to January 2009. Yongping earned a PhD in Biology/Biological Sciences from the University of Science and Technology of China, following a medical education at Anhui Medical University.